RCUS earnings: a positive outcome, +6.8%

On March 5, 2020, Arcus Biosciences, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.8% in the window around the event. It had already run +75.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.